Committee for Orphan Medicinal Products (COMP): 5-7 November 2019
Date:
05/11/2019 to 07/11/2019
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
Agenda - COMP agenda of the 05-07 November 2019 meeting (PDF/282.79 KB)
Draft
First published: 31/10/2019
Last updated: 04/11/2019
EMA/COMP/564928/2019 -
List item
COMP meeting report on the review of applications for orphan designation: November 2019 (PDF/176.46 KB)
First published: 18/11/2019
EMA/COMP/557148/2019 -
List item
Minutes of the COMP meeting 5-7 November 2019 (PDF/420.6 KB)
Adopted
First published: 25/02/2020
EMA/COMP/597430/2019